RCV-ap

Derivation of prognostic modelCordobo Garcia et al. 1993100
Location & dateBased on Framingham-Kannell 1976
Population characteristicsBased on Framingham-Kannell 1976
Inclusion, co-morbidityBased on Framingham-Kannell 1976
Risk factorsAge (3 groups)
Sex
Blood pressure (2 groups)
Tobacco consumption (yes/ no)
Cholesterolaemia (3 groups)
Glycaemia (2 groups)
OutcomeCVD
Prediction period16 years
Statistical methodsBased on Framingham-Kannell 1976
PracticalMultiplicative memory method
Authors notes
Modifications, tools or guidelines
External validation
Convergent validationVilaseca Canais et al. 199741 (Framingham Anderson, Dundee risk disk, Sheffield tables updated 1996)
Trials of health outcomes

From: Appendix 3, Prognostic models or risk scoring methods for use in targeting primary prevention of cardiovascular diseases (part completed)

Cover of A Systematic Review of Risk Scoring Methods and Clinical Decision Aids Used in the Primary Prevention of Coronary Heart Disease (Supplement)
A Systematic Review of Risk Scoring Methods and Clinical Decision Aids Used in the Primary Prevention of Coronary Heart Disease (Supplement) [Internet].
NICE Clinical Guidelines, No. 67S.
Beswick AD, Brindle P, Fahey T, et al.
Copyright © 2008, Royal College of General Practitioners.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.